inTEST updates FY24 revenue view to $145M-$155M

The company states: “At current exchange rates, Alfamation’s annual revenue in 2023 was approximately $25M and had backlog at December 31, 2023 of approximately $15M. The Company expects the acquisition to be accretive in 2025. Alfamation has generated healthy, double-digit, annual revenue growth over the last few years. As a result of the acquisition, revenue for full year 2024 is expected to be in the range of $145M to $155M. The acquisition is expected to be dilutive to earnings per diluted share in 2024, but accretive to non-GAAP adjusted earnings per diluted share due to the anticipated impacts associated with the amortization of intangible assets. Given the timing of the acquisition, the impact to first quarter 2024 results from operations are expected to be nominal.”